Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene
about
The emerging role of viral vectors as vehicles for DMD gene editingAdenoviral vectors encoding CRISPR/Cas9 multiplexes rescue dystrophin synthesis in unselected populations of DMD muscle cells.A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle CellsIn vivo gene editing in dystrophic mouse muscle and muscle stem cells.Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation.
P2860
Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@ast
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@en
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@nl
type
label
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@ast
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@en
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@nl
prefLabel
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@ast
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@en
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@nl
P2093
P2860
P3181
P1433
P1476
Clinical features of patients ...... 5-55 exon deletion of DMD gene
@en
P2093
Alberto Palladino
Annalaura Torella
Antonella Taglia
Chiara Orsini
Esther Picillo
Gerardo Nigro
Luigia Passamano
Luisa Politano
Manuela Ergoli
Marianna Scutifero
P2860
P3181
P407
P577
2015-05-01T00:00:00Z